Cover Image
Market Research Report
Product code 
1101874

Global Intravenous Immunoglobulin Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, and Others), By Application, By Regional Outlook and Forecast, 2022 - 2028

Published: | KBV Research | 209 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Intravenous Immunoglobulin Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, and Others), By Application, By Regional Outlook and Forecast, 2022 - 2028
Published: June 30, 2022
KBV Research
Content info: 209 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Global Intravenous Immunoglobulin Market size is expected to reach $17.3 billion by 2028, rising at a market growth of 6.9% CAGR during the forecast period.

Immunoglobulins are glycoprotein molecules that are produced by plasma or white blood cells. It plays a crucial role in the immune system's defense by identifying and attaching to certain antigens such as bacteria and viruses, assisting in the elimination. Intravenous immunoglobulins are immunoglobulins that are given via intravenous injection. This is because most patients receiving immunoglobulins are in hospitals or clinical settings, and intravenous immunoglobulins are the most prevalent mode of administration. This coupled with the demonstrated efficacy of the immunoglobulins as an efficient therapy choice for a number of immunological illnesses and the inadequate amount of training for home-care settings is also positively influencing the Intravenous Immunoglobulin market growth.

Several people may use IVIg instead of other medications to treat their immune system problems such as immunosuppressants, corticosteroids, or biological therapies. IVIg may be used in conjunction with immunosuppressants or other medications in some instances. The immune system of the body regularly produces enough antibodies to fight infection-causing bacteria. The body can't create enough of them if a patient has an immunological deficit. As a result, the patient is more susceptible to infections that can make a person very unwell. IVIg provides antibodies that the body doesn't produce on its own, allowing the patient to fight infections.

The medication may help the body raise low red blood-cell levels in autoimmune illnesses like lupus. If a person doesn't get enough of them, the person suffers from anaemia and weary. IVIg prevents lupus patients' white blood cells from damaging the red blood cells. The medication may stop the patient's immune system from destroying muscle cells if such a person has myositis.

COVID-19 Impact

The COVID-19 pandemic has presented both a threat and a lucrative opportunity for the IVIG business. The pandemic has also brought together a number of significant players and governments to support the development of novel COVID-19 hyper-immunoglobulins. Plasma-based medicines are being researched for their effectiveness in reducing problems due to severe acute viral respiratory infections, comprising COVID-19. This medication is derived from recovered patients' plasma. The market is likely to be driven by the pandemic, which is presently in its last phases. Many people with symptomatic secondary immunodeficiency (SID), auto-inflammatory disorders, primary immunodeficiency (PID), and C1 inhibitor deficiency were infected with the SARS-CoV-2 virus in the United Kingdom, some were hospitalized to hospitals, and few patients died.

Market Growth Factors

Growth in R&D activities in Intravenous Immunoglobulin

The medical system is witnessing the increasing immunoglobulin use, as well as a growth in the frequency of new launches and quick approval from government regulatory authorities around the world. For instance, as per the National Institutes of Health, a clinical trial to assess the safety, tolerability, and efficacy of a combination treatment regimen for coronavirus disease that includes the antiviral Remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2.The phase 3 trial, termed Inpatient Treatment with Anti-Coronavirus Immunoglobulin, or ITAC, was sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health.

Increase in cases of primary immunodeficiency diseases and preference for hospital treatment

Primary humoral immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), idiopathic thrombocytopenic purpura (ITP), Guillain-Barre syndrome, multifocal motor neuropathy (MMN), myasthenia gravis, Kawasaki disease, hypogammaglobulinemia, chronic lymphocytic leukemia, and others are among the indications for intravenous immunoglobulins. The medical system witnessed a rise in the prevalence of primary immunodeficiency disorders (PID) over the world. In patients with lymphoproliferative diseases, it is the most frequent chronic immunological deficiency (LPDs).

Market Restraining Factors

The likeliness of blood transfused diseases

The risk of contracting a blood-borne infection from blood donors who provide IVIG infusions is very minimal. This is due to the purifying procedure used to purify given blood plasma, which aids in the destruction of infectious organisms such as bacteria and viruses. Additionally, once the purification process is completed, IVIG donations are maintained and packed in sterilized packaging. This aids in the prevention of infectious disease transmission even more. Aseptic meningitis, a kind of non-infection-related brain inflammation, is a significant side effect of IVIG therapy.

Distribution Channel Outlook

Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty Pharmacy, and Others. The Speciality Pharmacy segment procured a substantial revenue share in the intravenous immunoglobulin market in 2021. This is because specialist pharmacies provide convenient treatment at home. Specialty medications are a vital and growing element of the pharmacy industry. As a result, the number of licensed specialty pharmaceuticals is fast expanding, propelling the specialty pharmacy industry forward over the forecast period.

Application Outlook

Based on Application, the market is segmented into Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia & Myasthenia Gravis, Congenital AIDS & Multifocal Motor Neuropathy, Kawasaki Disease, Guillain-Barre Syndrome, Immune thrombocytopenia (ITP), and Others. The chronic inflammatory demyelinating polyneuropathy segment garnered a significant revenue share in the intravenous immunoglobulin market in 2021. It is most commonly encountered in diabetic people. Immuno-suppressive medications, steroids, and plasmapheresis are all used in the treatment of CIDP. IVIG is a safe and effective alternative to these treatments. The market growth is aided by associated advantages such as safety, minimally invasive treatment, and user-friendly treatment options.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The Asia Pacific witnessed a promising revenue share in the intravenous immunoglobulin market in 2021. As a result of increased awareness and potential chances for the acceptance of immunoglobulin-based therapies for the treatment of primary immunological deficiencies, as well as a growing geriatric population. Emerging economies, rising healthcare spending, and the rapidly expanding immunoglobulin market are all contributing to the market growth. Moreover, the rising prevalence of immunological illnesses increased awareness of intravenous and subcutaneous immunoglobulin therapy, and improved healthcare facilities are expected to drive future growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Grifols, S.A., Takeda Pharmaceutical Company Limited, Baxter International, Inc., Biotest AG (Tiancheng International Investment Limited), LFB S.A., CSL Limited (CSL Behring), Octapharma AG, Kedrion S.p.A, and Bayer AG.

Strategies Deployed in Intravenous Immunoglobulin Market

Jan-2022: LFB came into a partnership with Kedrion, a provider of plasma-derived therapy. This partnership aimed to enable the companies to match the rising demands of the French market for immunoglobulins, drugs that are in great demand in France and across the world.

Jul-2021: Octapharma received approval from U.S. Food and Drug Administration (FDA) for Octagam 10% [Immune Globulin Intravenous (Human). This approval would enable the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis, a rare immune-mediated inflammatory disease.

Oct-2020: Grifols took over GC Pharma, a South Korean firm. This acquisition aimed to strengthen Grifols' presence in Canada, building on a legacy of partnership in Canada's blood system. In addition, this acquisition would reinforce the leadership and competitive gains provided by the plasma-center network. By raising the plasma collection and fractionation capacity, both companies would be able to continue ensuring that patients worldwide have safe and secure access to these life-saving plasma-derived medicines.

Mar-2020: Takeda Pharmaceuticals received approval from China's National Medical Products Administration (NMPA) for gut-selective biologic Entyvio (vedolizumab). This approval aimed to bring more treatment choices to clinicians and would allow more IBD patients to return to their normal daily lives.

Dec-2019: Grifols introduced the XEMBIFY (immune globulin subcutaneous human-klhw). This product aimed to better the lives and well-being of people who suffer from serious, rare, and chronic diseases. XEMBIFY is the company's first 20% subcutaneous immunoglobulin therapy for the treatment of patients 2 years of age and older with primary immunodeficiency (PI).

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Hospital Pharmacy
  • Specialty Pharmacy
  • Others

By Application

  • Immunodeficiency Diseases
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Hypogammaglobulinemia
  • Chronic Lymphocytic Leukemia & Myasthenia Gravis
  • Congenital AIDS & Multifocal Motor Neuropathy
  • Kawasaki Disease
  • Guillain-Barre Syndrome
  • Immune thrombocytopenia (ITP)
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Baxter International, Inc.
  • Biotest AG (Tiancheng International Investment Limited)
  • LFB S.A.
  • CSL Limited (CSL Behring)
  • Octapharma AG
  • Kedrion S.p.A
  • Bayer AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Intravenous Immunoglobulin Market, by Distribution Channel
    • 1.4.2 Global Intravenous Immunoglobulin Market, by Application
    • 1.4.3 Global Intravenous Immunoglobulin Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Intravenous Immunoglobulin Market by Distribution Channel

  • 3.1 Global Hospital Pharmacy Market by Region
  • 3.2 Global Specialty Pharmacy Market by Region
  • 3.3 Global Others Market by Region

Chapter 4. Global Intravenous Immunoglobulin Market by Application

  • 4.1 Global Immunodeficiency Diseases Market by Region
  • 4.2 Global Chronic Inflammatory Demyelinating Polyneuropathy Market by Region
  • 4.3 Global Hypogammaglobulinemia Market by Region
  • 4.4 Global Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Region
  • 4.5 Global Congenital AIDS & Multifocal Motor Neuropathy Market by Region
  • 4.6 Global Kawasaki Disease Market by Region
  • 4.7 Global Guillain-Barre Syndrome Market by Region
  • 4.8 Global Immune thrombocytopenia (ITP) Market by Region
  • 4.9 Global Others Market by Region

Chapter 5. Global Intravenous Immunoglobulin Market by Region

  • 5.1 North America Intravenous Immunoglobulin Market
    • 5.1.1 North America Intravenous Immunoglobulin Market by Distribution Channel
      • 5.1.1.1 North America Hospital Pharmacy Market by Country
      • 5.1.1.2 North America Specialty Pharmacy Market by Country
      • 5.1.1.3 North America Others Market by Country
    • 5.1.2 North America Intravenous Immunoglobulin Market by Application
      • 5.1.2.1 North America Immunodeficiency Diseases Market by Country
      • 5.1.2.2 North America Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
      • 5.1.2.3 North America Hypogammaglobulinemia Market by Country
      • 5.1.2.4 North America Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
      • 5.1.2.5 North America Congenital AIDS & Multifocal Motor Neuropathy Market by Country
      • 5.1.2.6 North America Kawasaki Disease Market by Country
      • 5.1.2.7 North America Guillain-Barre Syndrome Market by Country
      • 5.1.2.8 North America Immune thrombocytopenia (ITP) Market by Country
      • 5.1.2.9 North America Others Market by Country
    • 5.1.3 North America Intravenous Immunoglobulin Market by Country
      • 5.1.3.1 US Intravenous Immunoglobulin Market
        • 5.1.3.1.1 US Intravenous Immunoglobulin Market by Distribution Channel
        • 5.1.3.1.2 US Intravenous Immunoglobulin Market by Application
      • 5.1.3.2 Canada Intravenous Immunoglobulin Market
        • 5.1.3.2.1 Canada Intravenous Immunoglobulin Market by Distribution Channel
        • 5.1.3.2.2 Canada Intravenous Immunoglobulin Market by Application
      • 5.1.3.3 Mexico Intravenous Immunoglobulin Market
        • 5.1.3.3.1 Mexico Intravenous Immunoglobulin Market by Distribution Channel
        • 5.1.3.3.2 Mexico Intravenous Immunoglobulin Market by Application
      • 5.1.3.4 Rest of North America Intravenous Immunoglobulin Market
        • 5.1.3.4.1 Rest of North America Intravenous Immunoglobulin Market by Distribution Channel
        • 5.1.3.4.2 Rest of North America Intravenous Immunoglobulin Market by Application
  • 5.2 Europe Intravenous Immunoglobulin Market
    • 5.2.1 Europe Intravenous Immunoglobulin Market by Distribution Channel
      • 5.2.1.1 Europe Hospital Pharmacy Market by Country
      • 5.2.1.2 Europe Specialty Pharmacy Market by Country
      • 5.2.1.3 Europe Others Market by Country
    • 5.2.2 Europe Intravenous Immunoglobulin Market by Application
      • 5.2.2.1 Europe Immunodeficiency Diseases Market by Country
      • 5.2.2.2 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
      • 5.2.2.3 Europe Hypogammaglobulinemia Market by Country
      • 5.2.2.4 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
      • 5.2.2.5 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country
      • 5.2.2.6 Europe Kawasaki Disease Market by Country
      • 5.2.2.7 Europe Guillain-Barre Syndrome Market by Country
      • 5.2.2.8 Europe Immune thrombocytopenia (ITP) Market by Country
      • 5.2.2.9 Europe Others Market by Country
    • 5.2.3 Europe Intravenous Immunoglobulin Market by Country
      • 5.2.3.1 Germany Intravenous Immunoglobulin Market
        • 5.2.3.1.1 Germany Intravenous Immunoglobulin Market by Distribution Channel
        • 5.2.3.1.2 Germany Intravenous Immunoglobulin Market by Application
      • 5.2.3.2 UK Intravenous Immunoglobulin Market
        • 5.2.3.2.1 UK Intravenous Immunoglobulin Market by Distribution Channel
        • 5.2.3.2.2 UK Intravenous Immunoglobulin Market by Application
      • 5.2.3.3 France Intravenous Immunoglobulin Market
        • 5.2.3.3.1 France Intravenous Immunoglobulin Market by Distribution Channel
        • 5.2.3.3.2 France Intravenous Immunoglobulin Market by Application
      • 5.2.3.4 Russia Intravenous Immunoglobulin Market
        • 5.2.3.4.1 Russia Intravenous Immunoglobulin Market by Distribution Channel
        • 5.2.3.4.2 Russia Intravenous Immunoglobulin Market by Application
      • 5.2.3.5 Spain Intravenous Immunoglobulin Market
        • 5.2.3.5.1 Spain Intravenous Immunoglobulin Market by Distribution Channel
        • 5.2.3.5.2 Spain Intravenous Immunoglobulin Market by Application
      • 5.2.3.6 Italy Intravenous Immunoglobulin Market
        • 5.2.3.6.1 Italy Intravenous Immunoglobulin Market by Distribution Channel
        • 5.2.3.6.2 Italy Intravenous Immunoglobulin Market by Application
      • 5.2.3.7 Rest of Europe Intravenous Immunoglobulin Market
        • 5.2.3.7.1 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel
        • 5.2.3.7.2 Rest of Europe Intravenous Immunoglobulin Market by Application
  • 5.3 Asia Pacific Intravenous Immunoglobulin Market
    • 5.3.1 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
      • 5.3.1.1 Asia Pacific Hospital Pharmacy Market by Country
      • 5.3.1.2 Asia Pacific Specialty Pharmacy Market by Country
      • 5.3.1.3 Asia Pacific Others Market by Country
    • 5.3.2 Asia Pacific Intravenous Immunoglobulin Market by Application
      • 5.3.2.1 Asia Pacific Immunodeficiency Diseases Market by Country
      • 5.3.2.2 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
      • 5.3.2.3 Asia Pacific Hypogammaglobulinemia Market by Country
      • 5.3.2.4 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
      • 5.3.2.5 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country
      • 5.3.2.6 Asia Pacific Kawasaki Disease Market by Country
      • 5.3.2.7 Asia Pacific Guillain-Barre Syndrome Market by Country
      • 5.3.2.8 Asia Pacific Immune thrombocytopenia (ITP) Market by Country
      • 5.3.2.9 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Intravenous Immunoglobulin Market by Country
      • 5.3.3.1 China Intravenous Immunoglobulin Market
        • 5.3.3.1.1 China Intravenous Immunoglobulin Market by Distribution Channel
        • 5.3.3.1.2 China Intravenous Immunoglobulin Market by Application
      • 5.3.3.2 Japan Intravenous Immunoglobulin Market
        • 5.3.3.2.1 Japan Intravenous Immunoglobulin Market by Distribution Channel
        • 5.3.3.2.2 Japan Intravenous Immunoglobulin Market by Application
      • 5.3.3.3 India Intravenous Immunoglobulin Market
        • 5.3.3.3.1 India Intravenous Immunoglobulin Market by Distribution Channel
        • 5.3.3.3.2 India Intravenous Immunoglobulin Market by Application
      • 5.3.3.4 South Korea Intravenous Immunoglobulin Market
        • 5.3.3.4.1 South Korea Intravenous Immunoglobulin Market by Distribution Channel
        • 5.3.3.4.2 South Korea Intravenous Immunoglobulin Market by Application
      • 5.3.3.5 Singapore Intravenous Immunoglobulin Market
        • 5.3.3.5.1 Singapore Intravenous Immunoglobulin Market by Distribution Channel
        • 5.3.3.5.2 Singapore Intravenous Immunoglobulin Market by Application
      • 5.3.3.6 Malaysia Intravenous Immunoglobulin Market
        • 5.3.3.6.1 Malaysia Intravenous Immunoglobulin Market by Distribution Channel
        • 5.3.3.6.2 Malaysia Intravenous Immunoglobulin Market by Application
      • 5.3.3.7 Rest of Asia Pacific Intravenous Immunoglobulin Market
        • 5.3.3.7.1 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel
        • 5.3.3.7.2 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application
  • 5.4 LAMEA Intravenous Immunoglobulin Market
    • 5.4.1 LAMEA Intravenous Immunoglobulin Market by Distribution Channel
      • 5.4.1.1 LAMEA Hospital Pharmacy Market by Country
      • 5.4.1.2 LAMEA Specialty Pharmacy Market by Country
      • 5.4.1.3 LAMEA Others Market by Country
    • 5.4.2 LAMEA Intravenous Immunoglobulin Market by Application
      • 5.4.2.1 LAMEA Immunodeficiency Diseases Market by Country
      • 5.4.2.2 LAMEA Chronic Inflammatory Demyelinating Polyneuropathy Market by Country
      • 5.4.2.3 LAMEA Hypogammaglobulinemia Market by Country
      • 5.4.2.4 LAMEA Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country
      • 5.4.2.5 LAMEA Congenital AIDS & Multifocal Motor Neuropathy Market by Country
      • 5.4.2.6 LAMEA Kawasaki Disease Market by Country
      • 5.4.2.7 LAMEA Guillain-Barre Syndrome Market by Country
      • 5.4.2.8 LAMEA Immune thrombocytopenia (ITP) Market by Country
      • 5.4.2.9 LAMEA Others Market by Country
    • 5.4.3 LAMEA Intravenous Immunoglobulin Market by Country
      • 5.4.3.1 Brazil Intravenous Immunoglobulin Market
        • 5.4.3.1.1 Brazil Intravenous Immunoglobulin Market by Distribution Channel
        • 5.4.3.1.2 Brazil Intravenous Immunoglobulin Market by Application
      • 5.4.3.2 Argentina Intravenous Immunoglobulin Market
        • 5.4.3.2.1 Argentina Intravenous Immunoglobulin Market by Distribution Channel
        • 5.4.3.2.2 Argentina Intravenous Immunoglobulin Market by Application
      • 5.4.3.3 UAE Intravenous Immunoglobulin Market
        • 5.4.3.3.1 UAE Intravenous Immunoglobulin Market by Distribution Channel
        • 5.4.3.3.2 UAE Intravenous Immunoglobulin Market by Application
      • 5.4.3.4 Saudi Arabia Intravenous Immunoglobulin Market
        • 5.4.3.4.1 Saudi Arabia Intravenous Immunoglobulin Market by Distribution Channel
        • 5.4.3.4.2 Saudi Arabia Intravenous Immunoglobulin Market by Application
      • 5.4.3.5 South Africa Intravenous Immunoglobulin Market
        • 5.4.3.5.1 South Africa Intravenous Immunoglobulin Market by Distribution Channel
        • 5.4.3.5.2 South Africa Intravenous Immunoglobulin Market by Application
      • 5.4.3.6 Nigeria Intravenous Immunoglobulin Market
        • 5.4.3.6.1 Nigeria Intravenous Immunoglobulin Market by Distribution Channel
        • 5.4.3.6.2 Nigeria Intravenous Immunoglobulin Market by Application
      • 5.4.3.7 Rest of LAMEA Intravenous Immunoglobulin Market
        • 5.4.3.7.1 Rest of LAMEA Intravenous Immunoglobulin Market by Distribution Channel
        • 5.4.3.7.2 Rest of LAMEA Intravenous Immunoglobulin Market by Application

Chapter 6. Company Profiles

  • 6.1 Grifols, S.A
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Regional & Segmental Analysis
    • 6.1.4 Research & Development Expenses
    • 6.1.5 Recent strategies and developments:
      • 6.1.5.1 Product Launches and Product Expansions:
      • 6.1.5.2 Acquisition and Mergers:
  • 6.2 Takeda Pharmaceutical Company Limited
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Regional Analysis
    • 6.2.4 Research & Development Expense
    • 6.2.5 Recent strategies and developments:
      • 6.2.5.1 Approvals and Trials:
  • 6.3 Baxter International, Inc.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Regional Analysis
    • 6.3.4 Research & Development Expense
  • 6.4 Biotest AG (Tiancheng International Investment Limited)
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Segmental and Regional Analysis
    • 6.4.4 Research & Development Expense
  • 6.5 LFB S.A.
    • 6.5.1 Company Overview
    • 6.5.2 Recent strategies and developments:
      • 6.5.2.1 Partnerships, Collaborations, and Agreements:
  • 6.6 CSL Limited (CSL Behring)
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expense
  • 6.7 Octapharma AG
    • 6.7.1 Company Overview
    • 6.7.2 Recent strategies and developments:
      • 6.7.2.1 Approvals and Trials:
  • 6.8 Kedrion S.p.A
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Segmental and Regional Analysis
    • 6.8.4 Research & Development Expenses
  • 6.9 Bayer AG
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental and Regional Analysis
    • 6.9.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 Global Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 2 Global Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 3 Global Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Specialty Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Specialty Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 12 Global Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 13 Global Immunodeficiency Diseases Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Immunodeficiency Diseases Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Chronic Inflammatory Demyelinating Polyneuropathy Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Chronic Inflammatory Demyelinating Polyneuropathy Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Hypogammaglobulinemia Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Hypogammaglobulinemia Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Congenital AIDS & Multifocal Motor Neuropathy Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Congenital AIDS & Multifocal Motor Neuropathy Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Kawasaki Disease Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Kawasaki Disease Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Guillain-Barre Syndrome Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Guillain-Barre Syndrome Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Immune thrombocytopenia (ITP) Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Immune thrombocytopenia (ITP) Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Intravenous Immunoglobulin Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Intravenous Immunoglobulin Market by Region, 2022 - 2028, USD Million
  • TABLE 33 North America Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 34 North America Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 35 North America Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 36 North America Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 37 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 44 North America Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 45 North America Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Kawasaki Disease Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Kawasaki Disease Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 58 North America Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 59 North America Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
  • TABLE 61 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
  • TABLE 65 US Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 66 US Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 67 US Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 68 US Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 69 US Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 70 US Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 71 Canada Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 72 Canada Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 73 Canada Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 74 Canada Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 75 Canada Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 76 Canada Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 77 Mexico Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 78 Mexico Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 79 Mexico Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 80 Mexico Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 81 Mexico Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 82 Mexico Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 89 Europe Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 90 Europe Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 91 Europe Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 92 Europe Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 93 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 100 Europe Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 101 Europe Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Kawasaki Disease Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Kawasaki Disease Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Germany Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 122 Germany Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 123 Germany Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 124 Germany Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 125 Germany Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 126 Germany Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 127 UK Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 128 UK Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 129 UK Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 130 UK Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 131 UK Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 132 UK Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 133 France Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 134 France Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 135 France Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 136 France Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 137 France Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 138 France Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 139 Russia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 140 Russia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 141 Russia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 142 Russia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 143 Russia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 144 Russia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 145 Spain Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 146 Spain Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 147 Spain Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 148 Spain Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 149 Spain Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 150 Spain Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 151 Italy Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 152 Italy Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 153 Italy Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 154 Italy Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 155 Italy Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 156 Italy Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 157 Rest of Europe Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 158 Rest of Europe Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 159 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 Rest of Europe Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 Rest of Europe Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 162 Rest of Europe Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 163 Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 164 Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 165 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 166 Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 167 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 168 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 169 Asia Pacific Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 170 Asia Pacific Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 171 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 172 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Kawasaki Disease Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Kawasaki Disease Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
  • TABLE 195 China Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 196 China Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 197 China Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 198 China Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 199 China Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 200 China Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 201 Japan Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 202 Japan Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 203 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 204 Japan Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 205 Japan Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 206 Japan Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 207 India Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 208 India Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 209 India Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 210 India Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 211 India Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 212 India Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 213 South Korea Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 214 South Korea Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 215 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 216 South Korea Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 217 South Korea Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 218 South Korea Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 219 Singapore Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 220 Singapore Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 221 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 222 Singapore Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 223 Singapore Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 224 Singapore Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 225 Malaysia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 226 Malaysia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 227 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 228 Malaysia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 229 Malaysia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 230 Malaysia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 231 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 232 Rest of Asia Pacific Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 233 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 234 Rest of Asia Pacific Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 235 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 236 Rest of Asia Pacific Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 237 LAMEA Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 238 LAMEA Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 239 LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 240 LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 241 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 242 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 243 LAMEA Specialty Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 244 LAMEA Specialty Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 245 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 246 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 247 LAMEA Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 248 LAMEA Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 249 LAMEA Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
  • TABLE 250 LAMEA Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
  • TABLE 251 LAMEA Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 252 LAMEA Chronic Inflammatory Demyelinating Polyneuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 253 LAMEA Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
  • TABLE 254 LAMEA Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
  • TABLE 255 LAMEA Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2018 - 2021, USD Million
  • TABLE 256 LAMEA Chronic Lymphocytic Leukemia & Myasthenia Gravis Market by Country, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Congenital AIDS & Multifocal Motor Neuropathy Market by Country, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Kawasaki Disease Market by Country, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Kawasaki Disease Market by Country, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Guillain-Barre Syndrome Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Guillain-Barre Syndrome Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Immune thrombocytopenia (ITP) Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Immune thrombocytopenia (ITP) Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Intravenous Immunoglobulin Market by Country, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Intravenous Immunoglobulin Market by Country, 2022 - 2028, USD Million
  • TABLE 269 Brazil Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 270 Brazil Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 271 Brazil Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 272 Brazil Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 273 Brazil Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 274 Brazil Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 275 Argentina Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 276 Argentina Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 277 Argentina Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 278 Argentina Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 279 Argentina Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 280 Argentina Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 281 UAE Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 282 UAE Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 283 UAE Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 284 UAE Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 285 UAE Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 286 UAE Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 287 Saudi Arabia Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 288 Saudi Arabia Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 289 Saudi Arabia Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 290 Saudi Arabia Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 291 Saudi Arabia Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 292 Saudi Arabia Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 293 South Africa Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 294 South Africa Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 295 South Africa Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 296 South Africa Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 297 South Africa Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 298 South Africa Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 299 Nigeria Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 300 Nigeria Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 301 Nigeria Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 302 Nigeria Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 303 Nigeria Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 304 Nigeria Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 305 Rest of LAMEA Intravenous Immunoglobulin Market, 2018 - 2021, USD Million
  • TABLE 306 Rest of LAMEA Intravenous Immunoglobulin Market, 2022 - 2028, USD Million
  • TABLE 307 Rest of LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 308 Rest of LAMEA Intravenous Immunoglobulin Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 309 Rest of LAMEA Intravenous Immunoglobulin Market by Application, 2018 - 2021, USD Million
  • TABLE 310 Rest of LAMEA Intravenous Immunoglobulin Market by Application, 2022 - 2028, USD Million
  • TABLE 311 Key information - Grifols, S.A.
  • TABLE 312 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 313 Key Information - Baxter International, Inc.
  • TABLE 314 key information - Biotest AG
  • TABLE 315 Key Information - LFB S.A
  • TABLE 316 key Information - CSL Limited
  • TABLE 317 Key Information - Octapharma AG
  • TABLE 318 key Information - Kedrion S.p.A
  • TABLE 319 Key Information - Bayer AG

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Intravenous Immunoglobulin Market share by Distribution Channel, 2021
  • FIG 3 Global Intravenous Immunoglobulin Market share by Distribution Channel, 2028
  • FIG 4 Global Intravenous Immunoglobulin Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Intravenous Immunoglobulin Market share by Application, 2021
  • FIG 6 Global Intravenous Immunoglobulin Market share by Application, 2028
  • FIG 7 Global Intravenous Immunoglobulin Market by Application, 2018 - 2028, USD Million
  • FIG 8 Global Intravenous Immunoglobulin Market share by Region, 2021
  • FIG 9 Global Intravenous Immunoglobulin Market share by Region, 2028
  • FIG 10 Global Intravenous Immunoglobulin Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: Grifols, S.A.